Skip to main content

Animations

MJFF Publications

5331 - 5340 of 6560 Results
Title
Year
  • Year
  • 2018
  • 2024
  • 2024
  • 2024
  • 2018
  • 2017
  • 2024
  • 2018
  • 2024
  • 2018
  • Summary Details
    OPEN
    Title: Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s disease
    Journal Name: PeerJ
    Publisher: PeerJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7717/peerj.5539
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Biochemical Fractionation of Human α-Synuclein in a Drosophila Model of Synucleinopathies
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms25073643
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Self-supervised learning for human activity recognition using 700,000 person-days of wearable data
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-024-01062-3
    Citation Count: 119
  • Summary Details
    OPEN
    Title: Resequencing the complete SNCA locus in Indian patients with Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00676-4
    Citation Count: 5
  • Summary Details
    OPEN
    Title: GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-23795-4
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nsmb.3433
    Citation Count: 197
  • Summary Details
    OPEN
    Title: Development and Implementation of an Innovative Framework for Automated Radiomics Analysis in Neuroimaging
    Journal Name: Journal of Imaging
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/jimaging10040096
    Citation Count: 2
  • Summary Details
    OPEN
    Title: LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-018-0550-0
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/dad2.12589
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-018-0255-7
    Citation Count: 69
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.